Jeff Yass’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Jeff Yass’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-10,471	Closed	-$6.72K	–	10452
2014 Q4	$6K	Sell	10,471 -9,592	-48%	-$5.8K	﹤0.01%	9538
2014 Q3	$11K	Buy	+20,063	New	+$25.4K	﹤0.01%	9347
2014 Q2	–	Sell	-17,163	Closed	-$24.6K	–	10390
2014 Q1	$31K	Buy	+17,163	New	+$29K	﹤0.01%	8756
2013 Q4	–	Sell	-33,889	Closed	-$76.4K	–	9624
2013 Q3	$83K	Buy	+33,889	New	+$93.8K	﹤0.01%	8139

Other funds holding ONCY

VFS

VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NFG

Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Jeff Yass's ONCY Position: Q1 2015 in Review

Jeff Yass sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q1 2015, closing a stake of 10,471 shares — an estimated $6.72K sold.

Jeff Yass first reported a position in ONCY in Q3 2013 and held it in 4 quarters. The position peaked at $83K in Q3 2013. 29 funds tracked by Wall St. Rank hold ONCY as of Q1 2015.

Jeff Yass reported no remaining ONCOLYTICS BIOTECH INC position as of Q1 2015 after selling out during the quarter.
Jeff Yass sold 10,471 ONCOLYTICS BIOTECH INC shares in Q1 2015, an estimated $6.72K.
Jeff Yass first reported a position in ONCOLYTICS BIOTECH INC in Q3 2013 and held it in 4 quarters.
Jeff Yass's ONCOLYTICS BIOTECH INC position peaked at $83K in Q3 2013.
29 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q1 2015.

Based on Susquehanna International Group's 13F filing for Q1 2015, filed 15 May 2015.